APA citiranje

Kappel-Latif, S., Zacherl, J., Hejna, M., Westerhoff, M., Tamandl, D., Ba-Ssalamah, A., . . . Kandioler, D. (2018). • Pancho trial (p53-adapted neoadjuvant chemotherapy for resectable esophageal cancer) completed—mutation rate of the marker higher than expected. Eur Surg.

Citação norma Chicago

Kappel-Latif, Sonja, et al. "• Pancho Trial (p53-adapted Neoadjuvant Chemotherapy for Resectable Esophageal Cancer) Completed—mutation Rate of the Marker Higher Than Expected." Eur Surg 2018.

MLA citiranje

Kappel-Latif, Sonja, et al. "• Pancho Trial (p53-adapted Neoadjuvant Chemotherapy for Resectable Esophageal Cancer) Completed—mutation Rate of the Marker Higher Than Expected." Eur Surg 2018.